The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
The state of GPCR research in 2004
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The majority of drugs under development target cell surfaces.”
From Fluidic and Air-Stable Supported Lipid Bilayer and Cell-Mimicking Microarrays (2008) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Tu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80589-9 · Cited by 862 · cited 1×
“and its specific association with effector proteins (enzymes producing second messengers, or ion channels”
Gutkind, J. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.1839 · Cited by 812
Rhodopsin dimers in native disc membranes
Fotiadis, D., Liang, Y., Filipek, S., Saperstein, D. A., Engel, A., & Palczewski, K. (2003) · Nature · doi:10.1038/421127a · Cited by 749
Activation of rhodopsin: new insights from structural and biochemical studies
Okada, T., Ernst, O. P., Palczewski, K., & Hofmann, K. P. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01799-6 · Cited by 413 · cited 1×
“In addition, X-ray crystallography and modelling-based analyses of GPCRs have provided information on the ligand–receptor interaction interfac”
Pharmacology and physiology of human adrenergic receptor polymorphisms
Small, K. M., McGraw, D. W., & Liggett, S. B. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135823 · Cited by 323
Research works printed but not linked: 210
- Decaillot, F. M. et al. Opioid receptor random mutagenesis reveals a mechanism for G protein-coupled receptor activation. Nature Struct. Biol. 10, 629–636 (2003). · DOI
- Lembo, P. M. et al. Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nature Neurosci. 5, 201–209 (2002). · DOI · Paper page
- Lu, Z. L., Saldanha, J. W. & Hulme, E. C. Seven-transmembrane receptors: crystals clarify. Trends Pharmacol. Sci. 23, 140–146 (2002). · DOI
- Yamaguchi, T. Molecular constituents and phosphorylation-dependent regulation of the post-synaptic density. Mass Spec. Rev. 21, 266–286 (2002). · DOI · Paper page
- Gross, C. et al. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416, 396–400 (2002). · DOI · Paper page
- Ghanouni, P. et al. Functionally different agonists induce distinct conformations in the G protein coupling domain of the β2 adrenergic receptor. J. Biol. Chem. 276, 24433–24436 (2001). · DOI · Paper page
- Janetopoulos, C., Jin, T. & Devreotes, P. Receptor-mediated activation of heterotrimeric G-proteins in living cells. Science 291, 2408–2411 (2001). · DOI
- Vilardaga, J. P., Bunemann, M., Krasel, C., Castro, M. & Lohse, M. J. Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nature Biotechnol. 21, 807–812 (2003). · DOI · Paper page
- Yi, T. M., Kitano, H. & Simon, M. I. A quantitative characterization of the yeast heterotrimeric G protein cycle. Proc. Natl Acad. Sci. USA 100, 10764–10769 (2003). · DOI · Paper page
- Tunaru, S. et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nature Med. 9, 352–355 (2003). · DOI · Paper page
- Kieffer, B. L. Opioids: first lessons from knockout mice. Trends Pharmacol. Sci. 20, 19–26 (1999). · DOI · Paper page
- Roques, B. P., Daugé, V., Gacel, G. & Fournié-Zaluski, M. C. in Biological Psychiatry, Developments in Psychiatry. Vol. 7 (eds Shagass, C. et al.) 287–289 (Elsevier, New York, 1985).
- Chang, K. J., Porreca, F. & Woods, J. H. The Delta Receptor (Marcel Dekker, New York, 2004).
- Gether, U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21, 90–113 (2000). · DOI · Paper page
- Bockaert, J. et al. The 'magic tail' of G protein-coupled receptors: an anchorage for functional protein networks. FEBS Lett. 546, 65–72 (2003). · DOI · Paper page
- Xiang, Y. & Kobilka, B. The PDZ-binding motif of the β2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes. Proc. Natl Acad. Sci. USA 100, 10776–10781 (2003). · DOI
- Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001). · DOI · Paper page
- Seifert, R., Wenzel-Seifert, K. & Kobilka, B. K. GPCR–Gα fusion proteins: molecular analysis of receptor–G-protein coupling. Trends Pharmacol. Sci. 20, 383–389 (1999). · DOI
- Wenzel-Seifert, K., Hurt, C. M. & Seifert, R. High constitutive activity of the human formyl peptide receptor. J. Biol. Chem. 273, 24181–24189 (1998). · DOI
- Seifert, R., Lee, T. W., Lam, T. L. & Kobilka, B. K. Reconstitution of β2-adrenoceptor–GTP-binding protein interaction in Sf9 cells. High coupling efficiency in a β2-adrenoceptor–Gsα fusion protein. Eur. J. Biochem. 255, 369–382 (1998). · DOI
- Seifert, R. et al. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor. J. Pharmacol. Exp. Ther. 305, 1104–1115 (2003). · doi:10.1124/jpet.103.049619
- Wenzel-Seifert, K., Arthur, J. M., Liu, H. Y. & Seifert, R. Quantitative analysis of formyl peptide receptor coupling to Giα1, Giα2, and Giα3 . J. Biol. Chem. 274, 33259–33266 (1999). · DOI
- Houston, C., Wenzel-Seifert, K., Bürckstümmer, T. & Seifert, R. The human histamine H2-receptor couples more efficiently to Sf9 insect cell Gs-proteins than to insect cell Gq-proteins: limitations of Sf9 cells for the analysis of receptor/G-protein coupling. J. Neurochem. 80, 678–696 (2002). · DOI
- Gille, A. & Seifert, R. 2′(3′)-O-(N-methylanthraniloyl)-substituted GTP analogs: a novel class of potent competitive adenylyl cyclase inhibitors. J. Biol. Chem. 278, 12672–12679 (2003). · DOI
- Gille, A. & Seifert, R. Low-affinity interactions of BODIPY-FL-GTPγS and BODIPY-FL-GppNHp with Gi- and Gs-proteins. Naunyn-Schmiedeberg's Arch. Pharmacol. 368, 210–215 (2003). · DOI
- Gille, A. et al. Differential inhibition of adenylyl cyclase isoforms and soluble guanylyl cyclase by purine and pyrimidine nucleotides. J. Biol. Chem. 279, 19955–19969 (2004). · DOI
- Seifert, R., Wenzel-Seifert, K., Gether, U. & Kobilka, B. K. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations. J. Pharmacol. Exp. Ther. 297, 1218–1226 (2001).
- Furukawa, H. et al. Conformation of ligands bound to the muscarinic acetylcholine receptor. Mol. Pharmacol. 62, 778–787 (2002). · doi:10.1124/mol.62.4.778
- Luca, S. et al. The conformation of neurotensin bound to its G protein-coupled receptor. Proc. Natl Acad. Sci. USA 100, 10706–10711 (2003). · DOI · Paper page
- Banères, J. -L. & Parello, J. Structure-based analysis of GPCR function: conformational adaptation of both agonist and receptor upon leukotriene B4 binding to recombinant BLT1. J. Mol. Biol. 329, 815–829 (2003). · DOI · Paper page
- Peleg, G., Ghanouni, P., Kobilka, B. K. & Zare, R. N. Single-molecule spectroscopy of the β2 adrenergic receptor: observation of conformational substates in a membrane protein. Proc. Natl Acad. Sci. USA, 98, 8469–9474 (2001). · DOI
- Seifert, R. & Wenzel-Seifert, K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 366, 381–416 (2002). · DOI · Paper page
- Seifert, R., Gether, U., Wenzel-Seifert, K. & Kobilka, B. K. Effects of guanine, inosine and xanthine nucleotides on β2-adrenergic receptor/Gs interactions: evidence for multiple receptor conformations. Mol. Pharmacol. 56, 348–358 (1999). · DOI
- Steinberg, S. F. & Brunton, L. L. Compartmentation of G-protein-coupled signaling pathways in cardiac myocytes. Annu. Rev. Pharmacol. Toxicol. 41, 751–773 (2001). · DOI · Paper page
- Luttrell, L. M. & Lefkowitz, R. J. The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell. Sci. 115, 455–465 (2002). · DOI · Paper page
- George, S. R., O'Dowd, B. F. & Lee, S. P. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nature Rev. Drug Discov. 1, 808–820 (2002). · DOI · Paper page
- Angers, S., Salahpour, A. & Bouvier, M. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu. Rev. Pharmacol. Toxicol. 42, 409–435 (2002). · DOI · Paper page
- Bockaert, J. & Pin, J. P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18, 1723–1729 (1999). · DOI · Paper page
- Gbahou, F. et al. Protean agonism at histamine H3 receptors in vitro and in vivo. Proc. Natl Acad. Sci. USA 100, 11086–11091 (2003). · DOI
- Leff, P., Scaramellini, C., Law, C. & McKechnie, K. A three-state receptor model of agonist action. Trends Pharmacol. Sci. 18, 355–362 (1997). · doi:10.1016/s0165-6147(97)90664-7
- Kenakin, T. Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol. Sci. 24, 346–354 (2003). · DOI · Paper page
- Adan, R. A. H. & Kas, M. J. H. Inverse agonism gains weight. Trends Pharmacol. Sci. 24, 315–321 (2003). · DOI
- Smit, M. J. et al. Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. Proc. Natl Acad. Sci. USA 93, 6802–6807 (1996). · DOI · Paper page
- Kjelsberg, M. A., Cotecchia, S., Ostrowski, J., Caron, M. G. & Lefkowitz, R. J. Constitutive activation of the α1B adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation. J. Biol. Chem. 267, 1430–1433 (1992). · DOI · Paper page
- Chen, G. et al. Use of constitutive G-protein-coupled receptor activity for drug discovery. Mol. Pharmacol. 57, 125–134 (2000). · DOI
- Sakmar, T. P., Menon, S. T., Marin, E. P. & Awad, E. S. Rhodopsin: insights from recent structural and mutagenesis studies. Annu. Rev. Biophys. Biomol. Struct. 31, 443–484 (2002). · DOI · Paper page
- Swaminath, G. et al. Sequential binding of agonists to the β2 adrenoceptor. Kinetic evidence for intermediate conformational states. J. Biol. Chem. 279, 686–691 (2004). · DOI · Paper page
- Whistler, J. L., Chuang, H. H., Chu, P., Jan, L. Y. & von Zastrow, M. Functional dissociation of μ-opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23, 737–746 (1999). · DOI · Paper page
- Willins, D. L. et al. Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo. Ann. NY Acad. Sci. 861, 121–127 (1998). · DOI
- Seifert, R. & Wenzel-Seifert, K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Arch. Pharmacol. 366, 381–416 (2002). · DOI · Paper page
- Azzi, M. et al. β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. Proc. Natl Acad. Sci. USA 100, 11406–11411 (2003). · DOI · Paper page
- Morello, J. -P. et al. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J. Clin. Invest. 105, 887–895 (2000). · DOI · Paper page
- Kelley, M. et al. Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists. Mol. Pharmacol. 60, 1210–1225 (2001). · DOI
- Liang, X., Lu, Y., Wilkes, M., Neubert, T. A. & Resh, M. D. Organization of the G protein-coupled receptors rhodopsin and opsin in native membranes. J. Biol. Chem. 278, 21655–21662 (2003). · DOI · Paper page
- Neve, K. A. et al. Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor. Mol. Pharmacol. 60, 373–381 (2001). · DOI
- Ballesteros, J. A., Shi, L. & Javitch, J. A. Structural mimicry in G-protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure–function analysis of rhodopsin-like receptors. Mol. Pharmacol. 60, 1–19 (2001). · doi:10.1124/mol.60.1.1 · Paper page
- Malherbe, P. et al. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine. Mol. Pharmacol. 64, 823–832 (2003). · DOI
- Bissantz, C., Bernard, P., Hibert, M. & Rognan, D. Protein-based virtual screening of chemical databases. II. Are homology models of G-protein coupled receptors suitable targets? Proteins 50, 5–25 (2003). · DOI · Paper page
- Tsamis, F. et al. Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry. J. Virol. 77, 5201–5208 (2003). · DOI · Paper page
- Archer, E., Maigret, B., Escrieut, C., Pradayrol, L. & Fourmy, D. Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? Trends Pharmacol. Sci. 24, 36–40 (2003). · DOI
- Allen, S., Rigby-Singleton, S. M., Harris, H., Davies, M. C. & O'Shea, P. Measuring and visualizing single molecular interactions in biology. Biochem. Soc. Transactions 31, 1052–1057 (2003). · doi:10.1042/bst0311052
- MacKinnon, R. Potassium channels. FEBS Lett. 555, 62–65 (2003). · DOI · Paper page
- Dutzler, R., Campbell, E. B. & MacKinnon, R. Gating the selectivity filter in ClC chloride channels. Science 300, 108–112 (2003). · DOI · Paper page
- Bass, R. B. et al. The structures of BtuCD and MscS and their implications for transporter and channel function. FEBS Lett. 555, 111–115 (2003). · doi:10.1016/s0014-5793(03)01126-8
- White, J. F., Trinh, L. B., Shiloach, J. & Grisshammer, R. Automated large-scale purification of a G-protein-coupled receptor for neurotensin. FEBS Lett. 564, 289–293 (2004). · doi:10.1016/s0014-5793(04)00195-4
- Lundstrom, K. Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim. Biophys. Acta 1610, 90–96 (2003). · DOI
- Kobilka, B. K. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Anal. Biochem. 231, 269–271 (1995). · DOI · Paper page
- Banères, J. L. et al. Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J. Mol. Biol. 329, 801–814 (2003). · DOI
- Bertin, B., Freissmuth, M., Jockers, R., Strosberg, A. D. & Marullo, S. Cellular signaling by an agonist-activated recepto/Gsα fusion protein. Proc. Natl Acad. Sci. USA 91, 8827–8831 (1994). · DOI
- Martini, L. et al. NK1 receptor fused to β-arrestin displays a single-component, high-affinity molecular phenotype. Mol. Pharmacol. 62, 30–37 (2002). · DOI
- Fernandez, C. & Wüthrich, K. NMR solution structure determination of membrane proteins reconstituted in detergent micelles. FEBS Lett. 555, 144–150 (2003). · DOI
- Gether, U., Lin, S. & Kobilka, B. K. Fluorescent labeling of purified β2 adrenergic receptor. Evidence for ligand-specific conformational changes. J. Biol. Chem. 270, 28268–28275 (1995). · DOI · Paper page
- Abramson, J. et al. Structure and mechanism of the lactose permease of Escherichia coli. Science 301, 610–615 (2003). · DOI · Paper page
- Palanche, T. et al. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J. Biol.Chem. 276, 34853–34861 (2001). · DOI
- Jordan, B. A. & Devi, L. A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697–700 (1999). · DOI · Paper page
- Bowery, N. G. Mammalian γ-aminobutyric acid (B) receptors: structure and function. Pharmacol. Rev. 54, 247–264 (2002). · DOI · Paper page
- Wenzel-Seifert, K. & Seifert, R. Molecular analysis of β2-adrenoceptor coupling to Gs-, Gi-, and Gq-proteins. Mol. Pharmacol. 58, 954–966 (2000). · DOI
- Gille, A., Liu, H. Y., Sprang, S. R. & Seifert, R. Distinct interactions of GTP, UTP, and CTP with Gs-proteins. J. Biol. Chem. 277, 34434–34442 (2002). · DOI
- Noble, F. & Roques, B. P. in Understanding G-Protein-Coupled Receptors and their role in the CNS (eds Pangalos, M. & Davies, C.) 242–263 (Oxford Univ., Oxford, 2002). · doi:10.1093/oso/9780198509165.003.0014
- Marshall, F. H., Jones, K. A., Kaupmann, K. & Bettler, B. GABAB receptors — the first 7TM heterodimers. Trends Pharmacol. Sci. 20, 396–399 (1999). · DOI · Paper page
- Nelson, G. et al. Mammalian sweet taste receptors. Cell 106, 381–390 (2001). · DOI · Paper page
- Sexton, P. M., Albiston, A., Morfis, M. & Tilakaratne, N. Receptor activity modifying proteins. Cell. Signal. 13, 73–83 (2001). · DOI · Paper page
- Ramsay, D., Kellett, E., McVey, M., Rees, S. & Milligan, G. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. Biochem. J. 365, 429–440 (2002). · DOI · Paper page
- Mercier, J. F., Salahpour, A., Angers, S., Breit, A. & Bouvier, M. Quantitative assessment of β1- and β2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J. Biol. Chem. 277, 44925–44931 (2002). · DOI · Paper page
- Terrillon, S. et al. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. Mol. Endocrinol. 17, 677–691 (2003). · DOI · Paper page
- Hague, C., Uberti, M. A., Chen, Z., Hall, R. A. & Minneman, K. P. Cell surface expression of α1D-adrenergic receptors is controlled by heterodimerization with α1B-adrenergic receptors. J. Biol. Chem. 279, 15541–15549 (2004). · DOI · Paper page
- Jones, K. A. et al. GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2. Nature 396, 674–679 (1998). · DOI · Paper page
- White, J. H. et al. Heterodimerization is required for the formation of a functional GABAB receptor. Nature 396, 679–682 (1998). · DOI · Paper page
- Lee, S. P. et al. Dopamine D1 and D2 receptor coactivation generates a novel phospholipase C-mediated calcium signal. J. Biol. Chem. 24 May 2004 (doi: 10.1074/jbc.M401923200). · DOI · Paper page
- Kaupmann, K. et al. GABAB-receptor subtypes assemble into functional heteromeric complexes. Nature 396, 683–687 (1998). · DOI · Paper page
- Wreggett, K. A. & De Lean, A. The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland. Mol. Pharmacol. 26, 214–227 (1984).
- Park, P. S., Sum, C. S., Pawagi, A. B. & Wells, J. W. Cooperativity and oligomeric status of cardiac muscarinic cholinergic receptors. Biochemistry 41, 5588–5604 (2002). · doi:10.1021/bi011746s
- Gripentrog, J. M. et al. Experimental evidence for lack of homodimerization of the G protein-coupled human N-formyl peptide receptor. J. Immunol. 171, 3187–3193 (2003). · doi:10.4049/jimmunol.171.6.3187
- Nelson, G. et al. An amino-acid taste receptor. Nature 416, 199–202 (2002). · DOI · Paper page
- He, L., Fong, J., von Zastrow, M. & Whistler, J. L. Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 108, 271–282 (2002). · DOI · Paper page
- Kunishima, M. et al. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature 407, 971–977 (2000). · DOI · Paper page
- Duthey, B. et al. A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B) receptor. J. Biol. Chem. 277, 3236–3241 (2002). · DOI · Paper page
- Salahpour, A., Angers, S. & Bouvier, M. Functional significance of oligomerization of G-protein-coupled receptors. Trends Endocrinol. Metab. 11, 163–168 (2000). · DOI
- Marshall, F. H. Heterodimerization of G-protein-coupled receptors in the CNS. Curr. Opin. Pharmacol. 1, 40–44 (2001). · DOI
- Wenzel-Seifert, K. & Seifert, R. Functional differences between human formyl peptide receptor isoforms 26, 98 and G6. Naunyn-Schmiedeberg's Arch. Pharmacol. 367, 509–515 (2003). · DOI
- McGavin, J. K. & Keating, G. M. Bisoprolol: a review of its use in chronic heart failure. Drugs 62, 2677–2696 (2002). · DOI
- Engelhardt, S., Grimmer, Y., Fan, G. -H. & Lose, M. J. Constitutive activity of the human β1-adrenergic receptor in β1-receptor transgenic mice. Mol. Pharmacol. 60, 712–717 (2001).
- Kvols, K. L. et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N. Engl. J. Med. 315, 663–666 (1986). · DOI · Paper page
- Katugampola, S. & Davenport, A. Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system. Trends Pharmcol. Sci. 24, 30–35 (2003). · DOI
- Wise, A., Gearing, K. & Rees, S. Target validation of G-protein coupled receptors. Drug Discov. Today 7, 235–246 (2002). · DOI · Paper page
- Roques, B. P. Novel approaches to targeting neuropeptide systems. Trends Pharmacol. Sci. 21, 475–483 (2000). · DOI
- Strange, P. G. Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol. Rev. 53, 119–133 (2001).
- Gasparini, F., Kuhn, R. & Pin, J. P. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives. Curr. Opin. Pharmacol. 2, 43–49 (2002). · DOI
- May, L. T. & Christopoulos, A. Allosteric modulators of G-protein-coupled receptors. Curr. Opin. Pharmacol. 3, 551–556 (2003). · DOI
- Schaffhauser, H. et al. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. Mol. Pharmacol. 64, 798–810 (2003). · DOI · Paper page
- Seifert, R. et al. Differential effects of Gsα splice variants on β2-adrenoceptor-mediated signaling. The β2-adrenoceptor coupled to the long splice variant of Gsα has properties of a constitutively active receptor. J. Biol. Chem. 273, 5109–5116 (1998). · DOI
- Wenzel-Seifert, K., Kelley, M. T., Buschauer, A. & Seifert, A. Similar apparent constitutive activity of human histamine H2-receptor fused to long and short splice variants of Gsα. J. Pharmacol. Exp. Ther. 299, 1013–1020 (2001).
- Gille, A. & Seifert, R. Co-expression of the β2-adrenoceptor and dopamine D1-receptor with Gsα proteins in Sf9 cells: limitations in comparison with fusion proteins. Biochim. Biophys. Acta 1613, 101–114 (2003). · DOI
- Fischer, J. A., Muff, R. & Born, W. Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs). Biochem. Soc. Trans. 30, 455–460 (2002). · DOI
- Fujino, H. & Regan, J. W. Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer? Trends Pharmacol. Sci. 24, 335–340 (2003). · DOI
- Brady, A. E. & Limbird, L. E. G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell. Signal. 4, 297–309 (2002). · DOI · Paper page
- Mallee, J. J. et al. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists. J. Biol. Chem. 277, 14294–14298 (2002). · DOI · Paper page
- Morfis, M., Christopoulos, A. & Sexton, P. M. RAMPs: 5 years on, where to now? Trends Pharmacol. Sci. 24, 596–601 (2003). · DOI
- Ango, F. et al. Dendritic and axonal targeting of type 5 metabotropic glutamate receptor is regulated by Homer1 proteins and neuronal excitation. J. Neurosci. 20, 8710–8716 (2000). · DOI · Paper page
- Ango, F. et al. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature 411, 962–965 (2001). · DOI · Paper page
- Olson, W. C. et al. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. J. Virol. 73, 4145–4155 (1999). · DOI · Paper page
- Peter, J. C., Eftekhari, P., Billiald, P., Wallukat, G. & Hoebeke, J. scFv Single chain antibody variable fragment as inverse agonist of the β2-adrenergic receptor. J. Biol. Chem. 278, 36740–36747 (2003). · DOI
- Ogata, E. Parathyroid hormone-related protein as a potential target of therapy for cancer-associated morbidity. Cancer 88, 2909–2911 (2000). · doi:10.1002/1097-0142(20000615)88:12+<2909::aid-cncr5>3.0.co;2-7
- Kakonen, S. M. & Mundy, G. R. Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer 97 (Suppl. 3), 834–839 (2003). · DOI · Paper page
- Bowers, C. Y. Unnatural growth hormone-releasing peptide begets natural ghrelin. J. Clin. Endocrinol. Metab. 86, 1464–1469 (2001). · doi:10.1210/jcem.86.4.7431 · Paper page
- Mijares, A., Lebesgue, D., Wallukat, G. & Hoebeke, J. From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-β2-adrenoceptor antibody behave as antagonists. Mol. Pharmacol. 58, 373–379 (2000). · doi:10.1124/mol.58.2.373
- Shigemoto, R., Abe, T., Nomura, S., Nakanishi, S. & Hirano, T. Antibodies inactivating mGluR1 metabotropic glutamate receptor block long-term depression in cultured Purkinje cells. Neuron 12, 1245–1255 (1994). · DOI · Paper page
- Sillevis Smitt, P. et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. New Engl. J. Med. 342, 21–27 (2000). · DOI · Paper page
- Orgiazzi, J., Madec, A. M. & Ducottet, X. The role of stimulating, function-blocking and growth-blocking anti-TSH receptor antibodies (TRAbs) in GD, Hashimoto's disease and in atrophic thyroiditis. Ann. Endocrinol. 64, 31–36 (2003).
- Coffield, V. M., Jian, Q. & Su, L. A genetic approach to inactivating chemokine receptors using a modified viral protein. Nature Biotechnol. 21, 1321–1327 (2003). · DOI
- Dillon, S. B., Verghese, M. W. & Snyderman, R. Signal transduction in cells following binding of chemoattractants to membrane receptors. Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol. 55, 65–80 (1988). · doi:10.1007/bf02896561
- Seifert, R. & Wenzel-Seifert, K. Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodonttitis. J. Biol. Chem. 276, 42043–42049 (2001). · DOI
- Seifert, R. & Wenzel-Seifert, K. The human formyl peptide receptor as model system for constitutively active receptors. Life Sci. 73, 2263–2280 (2003). · DOI
- Rohrer, D. K. et al. Targeted disruption of the mouse β1-adrenergic receptor gene: developmental and cardiovascular effects. Proc. Natl Acad. Sci. USA 93, 7375–7380 (1996). · DOI · Paper page
- Roeske, W. R. & Wildenthal, K. Responsiveness to drugs and hormones in the murine model of cardiac ontogenesis. Pharmacol. Ther. 14, 55–66 (1981). · doi:10.1016/0163-7258(81)90010-3
- Murphy, P. M. Viral exploitation and subversion of the immune system through chemokine mimicry. Nature Immunol. 2, 116–122 (2001). · DOI · Paper page
- Turnbull, A. V. et al. Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats. Diabetes 51, 2441–2449 (2002). · DOI
- Spiegel, A. M. Defects in G protein-coupled signal transduction in human disease. Annu. Rev. Physiol. 58, 143–170 (1996). · DOI · Paper page
- Inui, A. Neuropeptide gene polymorphisms and human behavioural disorders. Nature Rev. Drug Discov. 2, 986–998 (2003). · DOI
- Brown, E. & MacLeod, R. J. Extracellular calcium sensing and extracellular calcium signalling. Physiol. Rev. 81, 239–297 (2001). · DOI · Paper page
- Rosenthal, W., Antaramian, A., Gilbert, S. & Birnbaumer, M. Nephrogenic diagetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. J. Biol. Chem. 268, 13030–13033 (1993). · DOI · Paper page
- Pollak, M. R. et al. Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation. Nature Genet. 8, 303–307 (1994). · DOI · Paper page
- Daub, H., Ulrich-Weiss, F., Wallasch, C. & Ullrich, A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379, 557–560 (1996). · DOI · Paper page
- Prenzel, N. et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB–EGE. Nature 402, 884–888 (1999). · DOI · Paper page
- Morello, J. P. & Bichet, D. G. Nephrogenic diabetes insipidus. Annu. Rev. Physiol. 63, 607–630 (2001). · DOI · Paper page
- Janovick, J. A., Maya-Nunez, G. & Conn, P. M. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. J. Clin. Endocrinol. Metab. 87, 3255–3262 (2002). · doi:10.1210/jcem.87.7.8582 · Paper page
- Illing, M. E., Rajan, R. S., Bence, N. F. & Kopito, R. R. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J. Biol. Chem. 277, 34150–34160 (2002). · DOI · Paper page
- Corvilain, B., Van Sande, J., Dumont, J. E. & Vassart, G. Somatic and germline mutations of the TSH receptor and thyroid diseases. Clin. Endocrinol. 55, 143–158 (2001). · DOI
- Sadée, W., Hoeg, E., Lucas, J. & Wang, D. Genetic variations in human G protein-coupled receptors: implications for drug therapy. AAPS PharmSci. 3, E22 (2001). · DOI
- O'Rahilly, S. Leptin: defining its role in humans by the clinical study of genetic disorders. Nutr. Rev. 60, S30–S34 (2002). · DOI
- Inui, A. Transgenic approach to the study of body weight regulation. Pharmacol. Rev. 52, 35–61 (2000).
- Willie, J. T., Chemelli, R. M., Sinton, C. M. & Yanagisawa, M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24, 429–458 (2001). · DOI · Paper page
- Hosoda, K. et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color mice. Cell 79, 1267–1276 (1994). · DOI · Paper page
- Gao, J. L., Lee, E. J. & Murphy, P. M. Impaired bacterial host defense in mice lacking the N-formylpeptide receptor. J. Exp. Med. 189, 657–662 (1999). · DOI · Paper page
- Redrobe, J. P., Dumont, Y., Herzog, H. & Quirion, R. Characterization of neuropeptide Y, Y2 receptor knockout mice in two animal models of learning and memory processing. J. Mol. Neurosci. 22, 159–166 (2004). · DOI
- Arvanitakis, L., Geras-Raaka, E., Varma, A., Gershengorn, M. C. & Cesarman, E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385, 347–350 (1997). · DOI · Paper page
- Hunter, A. J., Nolan, P. M. & Brown, S. D. Towards new models of disease and physiology in the neurosciences: the role of induced and naturally occurring mutations. Hum. Mol. Genet. 9, 893–900 (2000). · DOI
- Christopoulos, A. & Kenakin, T. G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54, 323–374 (2002). · DOI · Paper page
- Yanovski, S. Z. & Yanovski, J. A. Obesity. N. Engl. J. Med. 346, 591–602 (2002). · DOI · Paper page
- O'Dowd, B. et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136, 355–360 (1993). · DOI · Paper page
- Lee, D. K. et al. Discovery of a receptor related to the galanin receptors. FEBS Lett. 446, 103–107 (1999). · DOI · Paper page
- Quirion, R. & Weiss, A. S. Peptide E and other proenkephalin-derived peptides are potent κ opiate receptor agonists. Peptides 4, 445–449 (1983). · DOI
- Kniazeff, J., Galvez, T., Labesse, G. & Pin, J. P. No ligand binding in the GB2 subunit of the GABAB receptor is required for activation and allosteric interaction between the subunits. J. Neurosci. 22, 7352–7361 (2002). · DOI · Paper page
- Vassilatis, D. K. et al. The G protein-coupled receptor repertoires of human and mouse. Proc. Natl Acad. Sci. USA 100, 4903–4908 (2003). · DOI · Paper page
- Fujisawa, Y. et al. Orphan GPCR ligands related to obesity. Curr. Med. Chem. Central Nervous System Agents 3, 101–120 (2003). · doi:10.2174/1568015033477802
- Wise, A., Jupe, S. C. & Rees, S. The identification of ligands at orphan G-protein coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44, 43–66 (2004). · DOI · Paper page
- Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660 (1999). · DOI · Paper page
- Inui, A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nature Rev. Neurosci. 2, 551–560 (2001). · DOI · Paper page
- König, M. et al. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature 383, 535–538 (1996). · DOI · Paper page
- Liu, C., Wilson, S. J., Kuei, C. & Lovenberg, T. W. Comparison of human, mouse, rat and guinea pig histamine H4 receptors reveal substantial pharmacological species variation. J. Pharmacol. Exp. Ther. 299, 121–130 (2001).
- Mason, D. A., Moore, J. D., Green, S. A. & Liggett, S. B. A gain-of-function polymorphism in a G-protein coupling domain of the human β1-adrenergic receptor. J. Biol. Chem. 274, 12670–12674 (1999). · DOI · Paper page
- Wenzel-Seifert, K. & Seifert, R. Properties of Arg389–β1-adrenoceptor–Gsα fusion proteins: comparison with Gly389–β1-adrenoceptor–Gsα fusion proteins. Recept. Channels 9, 315–323 (2003). · doi:10.3109/713745179
- Weinshilboum, R. Pharmacogenetics: the future is here! Mol. Interventions 3, 118–122 (2003). · doi:10.1124/mi.3.3.118
- Taghzouti, K. et al. Cognition enhancing effects in young and old rats of pBC264, a selective CCK-B receptor agonist. Psychopharmacol. 143, 141–149 (1999). · DOI
- Neubig, R. R., Spedding, M., Kenakin, T. & Christopoulos, A. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology. Pharmacol. Rev. 55, 597–606 (2003). · DOI · Paper page
- Kenakin, T. Efficacy as a vector: the relative prevalence and paucity of inverse agonism. Mol. Pharmacol. 65, 2–11 (2004). · DOI · Paper page
- Milligan, G. & Bond, R. A. Inverse agonism and the regulation of receptor number. Trends Pharmacol. Sci. 18, 468–474 (1997). · doi:10.1016/s0165-6147(97)90685-4
- Christopoulos, A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nature Rev. Drug Discov. 1, 198–210 (2002). · DOI · Paper page
- Kenakin, T. Efficacy at G-protein-coupled receptors. Nature Rev. Drug Discov. 1, 103–110 (2002). · DOI · Paper page
- Samama, P., Cottecchia, S., Costa, T. & Lefkowitz, R. J. A mutation-induced activated state of the β2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268, 4625–4636 (1993). · DOI · Paper page
- Weiss, J. M., Morgan, P. H., Lutz, M. W. & Kenakin, T. P. The cubic ternary complex receptor-occupancy model. I. Model description. J. Theor. Biol. 178, 151–167 (1996). · doi:10.1006/jtbi.1996.0014
- Weiss, J. M., Morgan, P. H., Lutz, M. W. & Kenakin, T. P. The cubic ternary complex receptor-occupancy model. II. Understanding apparent affinity. J. Theor. Biol. 178, 169–182 (1996). · doi:10.1006/jtbi.1996.0015
- Weiss, J. M., Morgan, P. H., Lutz, M. W. & Kenakin, T. P. The cubic ternary complex receptor-occupancy model. III. Resurrecting efficacy. J. Theor. Biol. 178, 381–397 (1996). · DOI · Paper page
- Offermanns, S. & Melvin, I. Simon. Gα15 and Gα16 couple a wide variety of receptors to phospholipase C. J. Biol. Chem. 270, 15175–15180 (1995). · DOI · Paper page
- Milligan, G. & Rees, S. Chimaeric Gα proteins: their potential use in drug discovery. Trends Pharmacol. Sci. 20, 118–124 (1999). · doi:10.1016/s0165-6147(99)01320-6
- Milligan, G. The use of receptor–G-protein fusion proteins for the study of ligand activity. Receptors Channels 8, 309–317 (2002). · doi:10.1080/10606820214639
- Molinari P. et al. Promiscuous coupling at receptor–Gα fusion proteins. The receptor of one covalent complex interacts with the α-subunit of another. J. Biol. Chem. 278, 15778–15788 (2003). · doi:10.1074/jbc.m300731200
- Kraulis, P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. App. Crystall. 24, 946–950 (1991). · DOI · Paper page
- Merritt, E. A. & Bacon, D. J. Raster3D: Photorealistic molecular graphics. Methods. Enzymol. 277, 505–524 (1997). · DOI · Paper page
- Bouvier, M. Oligomerization of G-protein-coupled transmitter receptors. Nature Rev. Neurosci. 2, 274–286 (2001). · DOI · Paper page
- Arshavsky, V. Y., Lamb, T. D. & Pugh, E. N. Jr. G proteins and phototransduction. Annu. Rev. Physiol. 64, 153–187 (2002). · DOI · Paper page
- Blumer, J. R. & Lanier, S. M. Accessory proteins for G protein-signaling systems: activators of G protein signaling and other nonreceptor proteins influencing the activation state of G proteins. Receptor Channels 9, 195–120 (2003).
- Clapham, D. E. & Neer, E. J. G protein β-subunits. Annu. Rev. Pharmacol. Toxicol. 37, 167–203 (1997). · DOI · Paper page
- Dolphin, A. C. G protein modulation of voltage-gated calcium channels. Pharmacol. Rev. 55, 607–627 (2003). · DOI · Paper page
- Gilman, A. G. G proteins and regulation of adenylyl cyclase. Biosci. Reports 15, 65–97 (1995). · DOI · Paper page
- Hofmann, F., Lacinova, L. & Klugbauer N. Voltage-dependent calcium channels: from structure to function. Rev. Physiol. Biochem. Pharmacol. 139, 33–87 (1999). · DOI · Paper page
- Hollinger, S. & Hepler, J. R. Cellular regulation of RGS proteins: modulators and integrators of G protein signaling. Pharmacol. Rev. 54, 527–559 (2002). · DOI · Paper page
- Malbon, C. C. Insulin signalling: putting the 'G-' in protein–protein interactions. Biochem. J. 380, 11–12 (2004). · doi:10.1042/bj20040619
- Nürnberg, B. & Ahnert-Hilger, G. Potential roles of heterotrimeric G proteins of the endomembrane system. FEBS Lett. 389, 61–65 (1996). · DOI
- Nürnberg, B., Gudermann, T. & Schultz, G. Receptors and G proteins as primary components of transmembrane signal transduction. 2. G proteins: structure and function. J. Mol. Med. 73, 123–132 (1995). · DOI
200 of 210 shown
Cited by
The 7 TM G‐Protein‐Coupled Receptor Target Family
Jacoby, E., Bouhelal, R., Gerspacher, M., & Seuwen, K. (2006) · ChemMedChem · doi:10.1002/cmdc.200600134 · Cited by 359
Dopamine D2 receptors form higher order oligomers at physiological expression levels
Guo, W., Urizar, E., Kralikova, M., Mobarec, J. C., Shi, L., Filizola, M., & Javitch, J. A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.153 · Cited by 335
Role of cholesterol in the function and organization of G-protein coupled receptors
Pucadyil, T. J., & Chattopadhyay, A. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2006.02.002 · Cited by 296
Fluidic and Air-Stable Supported Lipid Bilayer and Cell-Mimicking Microarrays
Deng, Y., Wang, Y., Holtz, B., Li, J., Traaseth, N., Veglia, G., Stottrup, B. J., Elde, R., Pei, D., Guo, A., et al. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800049f · Cited by 95
Metadata
- Authors
- Participants., T. N. R. D. D. G. Q., & Ellis, C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-07
- Volume
- 3
- Issue
- 7
- Pages
- 577-626
- ISSN
- 1474-1776
- 1474-1784
- Cited by
- 68
- References
- 13
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The state of GPCR research in 2004. https://app.cochat.ai/papers/10.1038/nrd1458
- The paper
- Participants., T. N. R. D. D. G. Q., & Ellis, C. (2004). The state of GPCR research in 2004. Nature Reviews Drug Discovery. https://doi.org/10.1038/nrd1458
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.